APA (7th ed.) Citation

AC, N., CD, M., S, R., H, A., AY, S., MK, S., . . . KS, R. (2016). Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. PloS one, 11(9), e0163209. https://doi.org/10.1371/journal.pone.0163209

Chicago Style (17th ed.) Citation

AC, Nirvanappa, et al. "Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PloS One 11, no. 9 (2016): e0163209. https://doi.org/10.1371/journal.pone.0163209.

MLA (9th ed.) Citation

AC, Nirvanappa, et al. "Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PloS One, vol. 11, no. 9, 2016, p. e0163209, https://doi.org/10.1371/journal.pone.0163209.